Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods
- PMID: 30407897
- DOI: 10.1200/JCO.18.00420
Utility of Gonadotropin-Releasing Hormone Agonists for Fertility Preservation: Lack of Biologic Basis and the Need to Prioritize Proven Methods
Comment in
-
Reply to V. Turan et al.J Clin Oncol. 2019 Jan 1;37(1):88-89. doi: 10.1200/JCO.18.00599. Epub 2018 Nov 8. J Clin Oncol. 2019. PMID: 30407896 No abstract available.
-
Reply to V. Turan et al.J Clin Oncol. 2019 Jan 1;37(1):86-88. doi: 10.1200/JCO.18.00630. Epub 2018 Nov 8. J Clin Oncol. 2019. PMID: 30407898 No abstract available.
Comment on
-
Fertility Preservation by Endocrine Suppression of Ovarian Function Using Gonadotropin-Releasing Hormone Agonists: The End of the Controversy?J Clin Oncol. 2018 Jul 1;36(19):1895-1897. doi: 10.1200/JCO.2018.78.9347. Epub 2018 May 2. J Clin Oncol. 2018. PMID: 29718789 No abstract available.
-
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data.J Clin Oncol. 2018 Jul 1;36(19):1981-1990. doi: 10.1200/JCO.2018.78.0858. Epub 2018 May 2. J Clin Oncol. 2018. PMID: 29718793 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
